| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 30/11/2023 | 13h30 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 27/11/2023 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 27/11/2023 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 23h09 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 23h07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 23h05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 23h03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 23h03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 23h01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h51 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h43 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h42 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h41 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h41 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h40 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h39 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h39 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h38 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h38 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h37 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h37 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h35 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h32 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h31 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 22h26 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 20/11/2023 | 14h49 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 14/11/2023 | 12h04 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 03/01/2020 | 22h20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 03/01/2020 | 22h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |
| 03/01/2020 | 22h14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |